Lepu Research Development vs Cost Of Revenue Analysis

300003 Stock

12.03 0.03 0.25%

Lepu Medical financial indicator trend analysis is infinitely more than just investigating Lepu Medical Tech recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lepu Medical Tech is a good investment. Please check the relationship between Lepu Medical Research Development and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lepu Medical Tech Research Development account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Lepu Medical's Research Development and Cost Of Revenue is 0.95. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Lepu Medical Tech, assuming nothing else is changed. The correlation between historical values of Lepu Medical's Research Development and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Lepu Medical Tech are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Research Development i.e., Lepu Medical's Research Development and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Cost Of Revenue

Cost of Revenue is found on Lepu Medical Tech income statement and represents the costs associated with goods and services Lepu Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Lepu Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lepu Medical Tech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Tax Provision is expected to grow to about 305.9 M, whereas Selling General Administrative is forecasted to decline to about 1.1 B.

	2021	2022	2023	2024 (projected)
Operating Income	2.7B	2.9B	1.8B	1.3B
Total Revenue	10.7B	10.6B	8.0B	4.7B

Operating Income Total Revenue

Lepu Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.26	0.8	0.97	0.92	0.98	0.87	0.85	0.96	0.71	0.81	0.97	0.58	0.85	0.97	0.8	0.98	0.95	0.81	0.87	0.87	0.88	0.95	0.91	0.94	0.81
Other Current Liab	0.26		0.57	0.08	0.02	0.19	0.44	0.22	0.19	0.65	-0.11	0.13	0.58	0.62	0.27	0.5	0.18	0.41	0.16	0.55	0.15	0.25	0.37	0.1	0.21	-0.15
Total Current Liabilities	0.8	0.57		0.67	0.55	0.72	0.86	0.75	0.74	0.94	0.38	0.67	0.4	0.96	0.81	0.87	0.69	0.87	0.59	0.82	0.64	0.76	0.86	0.72	0.77	0.45
Total Stockholder Equity	0.97	0.08	0.67		0.97	0.98	0.8	0.84	0.95	0.56	0.89	0.99	0.55	0.72	0.93	0.7	0.99	0.89	0.84	0.76	0.85	0.86	0.88	0.91	0.93	0.84
Other Liab	0.92	0.02	0.55	0.97		0.96	0.78	0.81	0.9	0.41	0.96	0.98	0.6	0.64	0.88	0.59	0.97	0.84	0.87	0.74	0.85	0.87	0.83	0.91	0.92	0.82
Retained Earnings	0.98	0.19	0.72	0.98	0.96		0.85	0.83	0.97	0.6	0.87	0.99	0.6	0.78	0.96	0.72	1.0	0.92	0.86	0.82	0.83	0.91	0.93	0.92	0.96	0.8
Accounts Payable	0.87	0.44	0.86	0.8	0.78	0.85		0.94	0.79	0.73	0.71	0.84	0.63	0.92	0.84	0.82	0.83	0.93	0.85	0.85	0.75	0.92	0.84	0.92	0.89	0.47
Cash	0.85	0.22	0.75	0.84	0.81	0.83	0.94		0.76	0.61	0.78	0.85	0.58	0.8	0.77	0.78	0.82	0.89	0.87	0.73	0.76	0.87	0.74	0.94	0.86	0.52
Other Assets	0.96	0.19	0.74	0.95	0.9	0.97	0.79	0.76		0.63	0.77	0.95	0.54	0.77	0.94	0.73	0.97	0.88	0.82	0.79	0.77	0.87	0.93	0.87	0.94	0.81
Net Receivables	0.71	0.65	0.94	0.56	0.41	0.6	0.73	0.61	0.63		0.22	0.54	0.4	0.92	0.74	0.89	0.58	0.78	0.41	0.8	0.59	0.6	0.78	0.53	0.62	0.41
Short Term Investments	0.81	-0.11	0.38	0.89	0.96	0.87	0.71	0.78	0.77	0.22		0.91	0.55	0.49	0.75	0.44	0.89	0.72	0.83	0.61	0.8	0.78	0.68	0.87	0.82	0.73
Inventory	0.97	0.13	0.67	0.99	0.98	0.99	0.84	0.85	0.95	0.54	0.91		0.6	0.74	0.93	0.69	0.99	0.9	0.88	0.78	0.84	0.89	0.89	0.94	0.94	0.8
Other Current Assets	0.58	0.58	0.4	0.55	0.6	0.6	0.63	0.58	0.54	0.4	0.55	0.6		0.58	0.53	0.59	0.63	0.66	0.7	0.68	0.47	0.65	0.53	0.52	0.59	0.3
Total Liab	0.85	0.62	0.96	0.72	0.64	0.78	0.92	0.8	0.77	0.92	0.49	0.74	0.58		0.85	0.92	0.76	0.92	0.69	0.93	0.74	0.83	0.9	0.77	0.83	0.5
Intangible Assets	0.97	0.27	0.81	0.93	0.88	0.96	0.84	0.77	0.94	0.74	0.75	0.93	0.53	0.85		0.79	0.95	0.92	0.76	0.88	0.86	0.86	0.96	0.86	0.93	0.82
Common Stock	0.8	0.5	0.87	0.7	0.59	0.72	0.82	0.78	0.73	0.89	0.44	0.69	0.59	0.92	0.79		0.71	0.88	0.66	0.87	0.7	0.76	0.82	0.7	0.75	0.5
Property Plant Equipment	0.98	0.18	0.69	0.99	0.97	1.0	0.83	0.82	0.97	0.58	0.89	0.99	0.63	0.76	0.95	0.71		0.91	0.86	0.82	0.85	0.9	0.92	0.91	0.95	0.82
Good Will	0.95	0.41	0.87	0.89	0.84	0.92	0.93	0.89	0.88	0.78	0.72	0.9	0.66	0.92	0.92	0.88	0.91		0.83	0.88	0.79	0.91	0.91	0.88	0.91	0.66
Net Tangible Assets	0.81	0.16	0.59	0.84	0.87	0.86	0.85	0.87	0.82	0.41	0.83	0.88	0.7	0.69	0.76	0.66	0.86	0.83		0.69	0.66	0.94	0.74	0.93	0.92	0.57
Long Term Debt	0.87	0.55	0.82	0.76	0.74	0.82	0.85	0.73	0.79	0.8	0.61	0.78	0.68	0.93	0.88	0.87	0.82	0.88	0.69		0.86	0.81	0.93	0.75	0.84	0.64
Other Stockholder Equity	0.87	0.15	0.64	0.85	0.85	0.83	0.75	0.76	0.77	0.59	0.8	0.84	0.47	0.74	0.86	0.7	0.85	0.79	0.66	0.86		0.73	0.84	0.82	0.82	0.81
Deferred Long Term Liab	0.88	0.25	0.76	0.86	0.87	0.91	0.92	0.87	0.87	0.6	0.78	0.89	0.65	0.83	0.86	0.76	0.9	0.91	0.94	0.81	0.73		0.87	0.94	0.97	0.64
Long Term Investments	0.95	0.37	0.86	0.88	0.83	0.93	0.84	0.74	0.93	0.78	0.68	0.89	0.53	0.9	0.96	0.82	0.92	0.91	0.74	0.93	0.84	0.87		0.83	0.93	0.77
Total Current Assets	0.91	0.1	0.72	0.91	0.91	0.92	0.92	0.94	0.87	0.53	0.87	0.94	0.52	0.77	0.86	0.7	0.91	0.88	0.93	0.75	0.82	0.94	0.83		0.95	0.66
Non Current Assets Total	0.94	0.21	0.77	0.93	0.92	0.96	0.89	0.86	0.94	0.62	0.82	0.94	0.59	0.83	0.93	0.75	0.95	0.91	0.92	0.84	0.82	0.97	0.93	0.95		0.77
Non Currrent Assets Other	0.81	-0.15	0.45	0.84	0.82	0.8	0.47	0.52	0.81	0.41	0.73	0.8	0.3	0.5	0.82	0.5	0.82	0.66	0.57	0.64	0.81	0.64	0.77	0.66	0.77

Click cells to compare fundamentals

Lepu Medical Account Relationship Matchups

Lepu Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.9B	18.2B	20.7B	24.5B	25.0B	26.3B
Other Current Liab	473.3M	766.7M	824.4M	109.8M	62.5M	59.3M
Total Current Liabilities	5.1B	4.8B	3.3B	5.3B	3.8B	2.5B
Total Stockholder Equity	7.5B	9.9B	11.5B	15.1B	16.0B	16.8B
Other Liab	237.0M	352.9M	473.7M	1.1B	1.2B	1.3B
Retained Earnings	5.8B	7.3B	8.7B	9.6B	10.2B	10.7B
Accounts Payable	822.3M	821.0M	1.4B	1.5B	1.0B	542.5M
Cash	2.0B	2.4B	3.8B	5.5B	4.2B	2.2B
Other Assets	1.5B	2.2B	1.7B	2.1B	2.5B	2.6B
Net Receivables	2.5B	2.1B	1.7B	1.9B	1.8B	1.4B
Inventory	1.0B	1.4B	1.9B	2.3B	2.3B	2.4B
Other Current Assets	92.7M	175.6M	288.4M	90.4M	188.0M	119.5M
Total Liab	7.9B	7.6B	8.4B	8.1B	7.5B	4.2B
Intangible Assets	2.0B	1.9B	2.1B	2.4B	2.7B	2.8B
Property Plant Equipment	1.8B	2.1B	2.7B	3.5B	4.1B	4.3B
Good Will	2.7B	2.8B	3.3B	3.3B	3.5B	2.7B
Net Tangible Assets	2.9B	3.3B	5.7B	6.8B	7.8B	4.3B
Long Term Debt	2.5B	2.3B	3.9B	2.2B	3.1B	2.6B
Other Stockholder Equity	342.2M	113.2M	37.5M	343.7M	395.2M	415.0M
Deferred Long Term Liab	418.1M	698.5M	681.9M	909.3M	1.0B	544.2M
Total Current Assets	5.6B	6.6B	8.1B	10.7B	9.3B	7.2B
Non Current Assets Total	10.3B	11.6B	12.6B	13.7B	15.7B	11.9B
Non Currrent Assets Other	489.3M	241.4M	298.4M	446.1M	1.3B	1.3B
Non Current Liabilities Total	2.8B	2.8B	5.1B	2.8B	3.8B	3.4B
Short Long Term Debt	1.5B	1.9B	583.9M	380.8M	1.0B	936.7M
Non Current Liabilities Other	2.4B	3.2B	2.5B	680.0M	612.0M	581.4M
Net Debt	2.9B	2.0B	1.8B	669.3M	602.3M	572.2M
Net Invested Capital	11.4B	14.1B	15.9B	17.8B	20.1B	15.9B
Net Working Capital	523.9M	1.8B	4.8B	5.4B	5.6B	3.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Lepu Stock

Balance Sheet is a snapshot of the financial position of Lepu Medical Tech at a specified time, usually calculated after every quarter, six months, or one year. Lepu Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lepu Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lepu currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lepu Research Development vs Cost Of Revenue Analysis

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Research Development

Cost Of Revenue

Lepu Medical fundamental ratios Correlations

Lepu Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lepu Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Lepu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant Equipment	+ 1.0	Retained Earnings
Inventory	+ 0.99	Total Stockholder Equity
Property Plant Equipment	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Retained Earnings
Property Plant Equipment	+ 0.99	Inventory
Retained Earnings	+ 0.98	Total Assets

Non Currrent Assets Other	- 0.15	Other Current Liab
Short Term Investments	- 0.11	Other Current Liab